Impaired fMRI activation in patients with primary brain tumors. - Wikidata - awgldk - TriplyDB

Impaired fMRI activation in patients with primary brain tumors.

Impaired fMRI activation in patients with primary brain tumors.

http://www.wikidata.org/entity/Q42471180

about

The role of functional imaging in the tumor patient The effects of antiepileptic drugs on cognitive functional magnetic resonance imaging Brain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus.Functional Magnetic Resonance Imaging for Preoperative Planning in Brain Tumour Surgery.Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI Neurosurgery for brain tumors: update on recent technical advances.Pathophysiological interference with neurovascular coupling - when imaging based on hemoglobin might go blind.Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumors Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas.Motor deficits correlate with resting state motor network connectivity in patients with brain tumours.Influence of Vascular Variant of the Posterior Cerebral Artery (PCA) on Cerebral Blood Flow, Vascular Response to CO2 and Static Functional Connectivity The impact of high grade glial neoplasms on human cortical electrophysiology The Resting-State Functional Magnetic Resonance Imaging Regional Homogeneity Metrics-Kendall's Coefficient of Concordance-Regional Homogeneity and Coherence-Regional Homogeneity-Are Valid Indicators of Tumor-Related Neurovascular Uncoupling.High-speed real-time resting-state FMRI using multi-slab echo-volumar imaging Comparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imaging Glioblastoma Induces Vascular Dysregulation in Nonenhancing Peritumoral Regions in Humans A review of orbital and intracranial magnetic resonance imaging in 79 canine and 13 feline patients (2004-2010).Effectiveness of four different clinical fMRI paradigms for preoperative regional determination of language lateralization in patients with brain tumors.Value of Frequency Domain Resting-State Functional Magnetic Resonance Imaging Metrics Amplitude of Low-Frequency Fluctuation and Functional Amplitude of Low-Frequency Fluctuation in the Assessment of Brain Tumor-Induced Neurovascular Uncoupling.Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting.Alteration of long-distance functional connectivity and network topology in patients with supratentorial gliomas.Neurovascular uncoupling in resting state fMRI demonstrated in patients with primary brain gliomas.Demonstration of Brain Tumor-Induced Neurovascular Uncoupling in Resting-State fMRI at Ultrahigh Field.Re-examine tumor-induced alterations in hemodynamic responses of BOLD fMRI: implications in presurgical brain mapping.Levodopa does not change cerebral vasoreactivity in Parkinson's disease.Resting state fMRI feature-based cerebral glioma grading by support vector machine.Local Glioma Cells Are Associated with Vascular Dysregulation.Limitations of Resting-State Functional MR Imaging in the Setting of Focal Brain Lesions.Task and task-free FMRI reproducibility comparison for motor network identification.Functional arterial spin labeling: Optimal sequence duration for motor activation mapping in clinical practice.Reduced CMRO₂ and cerebrovascular reserve in patients with severe intracranial arterial stenosis: a combined multiparametric qBOLD oxygenation and BOLD fMRI study.Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.Brain tumors disrupt the resting-state connectome.

P2860

Q26998680-893C14D2-E997-4DCD-8810-64DDE9609D51 Q27005706-AC986698-C3F0-4075-812E-96CC9385691C Q31112813-B5D9A8C1-4004-45B8-AC9C-8CA970926E03 Q31150618-ECB28297-4BB1-4F1C-AB44-CF3CE74599D5 Q33563593-D1491A67-F227-49CC-B940-F41D0B472C5C Q33822509-99B960E6-C9E0-4033-9A9D-649A4D1457A5 Q34201699-A68572BA-15F1-4FA5-A8D6-FFA7892D7375 Q34499649-A9309BF5-DA64-421A-B643-4D204196A31F Q35607009-CE9FCDAF-64CF-44C4-B767-1F281A51AC31 Q35888660-08D9B4B4-7EC2-404E-97CF-3EBDE1801E50 Q36105798-5CB0ACDF-C304-422C-8865-6F40E847F320 Q36314875-550D1943-50ED-4818-8294-72E3B74E3996 Q36330420-C9B331E6-D6E4-47E9-8426-7F537FF29330 Q37118722-C356BD41-6070-4BF7-9AFE-28921B5159D7 Q37298292-54DB5231-4585-4FBF-B7EA-C42485F2F3FA Q37585900-48D15F43-B3F3-484A-A02B-ECBD96446BE6 Q37898179-302A8C45-F558-476C-BF39-8A4FC86234A6 Q38468810-E50CD81D-4D46-446B-813D-99634B004959 Q38705302-D73B79EA-516C-4EAF-AA4E-1DABAF08CA16 Q39464173-1765EF17-053E-4B9D-8D54-AEA46FDE19AA Q40243815-03C6EF6E-7C3B-4053-AB37-48A36964A6FF Q40707493-24EE06E7-9278-449B-9F81-EFAC77F81FB7 Q41850681-A7C79CF2-2C41-4D16-9086-1163A45224C4 Q44095668-9EF6D5D4-A04A-483D-974A-B5BAE529FC9A Q45762726-E6567B21-F4D5-43E5-B27A-18C580C51C1D Q47436092-A3D0370F-86CB-42F3-9495-7ACEAA221038 Q47839222-FC0F063E-3BFC-4447-94E1-76D1C15D32C4 Q47911560-C6C99B2F-869A-49D6-821A-09323EBCE268 Q48372569-A25DF0EC-29FF-47EC-B897-8AFA38E5DB96 Q48397308-2478B3F0-9ECD-4E0D-8275-312707642452 Q48488458-763ADFD1-01C5-4863-85F2-0EDB3E889B3A Q48635940-5A5275D4-47F1-4A22-8B87-C4354397BD34 Q55266169-CA8BBDCD-3ACE-4AB6-BA15-8DD9A3830B9B

P2860

Impaired fMRI activation in patients with primary brain tumors.

http://www.wikidata.org/entity/Q42471180

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Impaired fMRI activation in patients with primary brain tumors.

@en

Impaired fMRI activation in patients with primary brain tumors.

@nl

type

label

Impaired fMRI activation in patients with primary brain tumors.

@en

Impaired fMRI activation in patients with primary brain tumors.

@nl

prefLabel

Impaired fMRI activation in patients with primary brain tumors.

@en

Impaired fMRI activation in patients with primary brain tumors.

@nl

P1433

Q42471180-2E3FA86C-E56E-4278-BDC4-7BF3B638F62A

P1476

Q42471180-B78C3D1C-1EB3-44E7-91C7-65A5BC44111F

P2093

Q42471180-0E7F50D4-E29D-4003-98FF-458F7F6567CA

Q42471180-3AB38877-3BFE-41F0-A940-A3A910485900

Q42471180-44E91746-FBDE-41B2-98C8-B681AAE522BD

Q42471180-5564F442-6F00-4026-A196-942D88BB6C23

Q42471180-55EFBEB4-DDF0-4E34-9E27-196D0F3C00FE

Q42471180-783B215B-2941-49E0-B4A8-B4BB67D6993B

Q42471180-A4AA0899-C2C8-43FE-8757-911947E0C28C

Q42471180-D470B8B6-A674-4801-8731-E37370D51E73

Q42471180-E0A98F11-65E3-4F14-8357-FA926EEE437A

Q42471180-EA90CDE6-55A6-4485-88C5-1C0FBFBD3D2D

P304

Q42471180-9CC85DCA-B193-40FA-826A-4E4266DC0F4E

P31

Q42471180-A857802F-2FA5-489C-A7EC-2BBA11321B60

P356

Q42471180-BB79F46B-7EA3-47B6-9120-FAD2D2C5B506

P407

Q42471180-6282131A-D852-4845-AAF0-0B66FAC4B9B7

P433

Q42471180-0B132600-A3CE-4BAA-BBC1-3433F800C316

P478

Q42471180-A5174B9F-6A35-45A8-8234-B076A72E8615

P50

Q42471180-C986FC47-9CB7-4E2B-8B1F-906A497F324E

Q42471180-DA00058B-24DA-4795-90D3-C9E94BAEE097

Q42471180-EE0886D8-4648-4940-8BA5-F5E22484B809

P577

Q42471180-923EA826-3BB4-4EE9-8281-5B61AABEF594

P5875

Q42471180-2E1A66DC-3D86-42F8-BA28-081C122CF7B5

P698

Q42471180-85FA8AFA-F970-4BE8-8839-EEBD6A8C4837

P356

J.NEUROIMAGE.2010.04.194

P1433

P1476

Impaired fMRI activation in patients with primary brain tumors.

@en

P2093

Alexandre Krainik

http://www.w3.org/2001/XMLSchema#string

Caroline Pasteris

http://www.w3.org/2001/XMLSchema#string

Caroline Salon

http://www.w3.org/2001/XMLSchema#string

Christoph Segebarth

http://www.w3.org/2001/XMLSchema#string

Dominique Hoffmann

http://www.w3.org/2001/XMLSchema#string

Eduardo Ramos Bombìn

http://www.w3.org/2001/XMLSchema#string

Emmanuel Gay

http://www.w3.org/2001/XMLSchema#string

François Berger

http://www.w3.org/2001/XMLSchema#string

Irène Troprès

http://www.w3.org/2001/XMLSchema#string

Jan Warnking

http://www.w3.org/2001/XMLSchema#string

P304

538-548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROIMAGE.2010.04.194

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel L Barbier

Nicolas Pannetier

P577

2010-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44582526

http://www.w3.org/2001/XMLSchema#string

P698

20452442

http://www.w3.org/2001/XMLSchema#string